Browse by category

AOMs result in 8% relative risk reduction in any CVD events in patients with obesity

The utilisation of anti-obesity medications (AOMs) among people with obesity could potentially alleviate the high prevalence of...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

24 hours ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

1 day ago

Racial and ethnic groups face barriers to obtaining OMMs

1 day ago

Weekly Digest